首页 | 本学科首页   官方微博 | 高级检索  
检索        


Primary B-cell lymphoma of the cauda equina, successfully treated with high-dose methotrexate plus high-dose cytarabine: a case report with MRI findings
Authors:Hiroko Nishida  Masao Hori  Katsuyuki Obara
Institution:(1) Department of Internal Medicine, Mito Red Cross Hospital, 3-12-48 Sannoaru, Mito Ibaragi, 310-0011, Japan;(2) Department of Pathology, Mito Red Cross Hospital, Mito, Ibaragi, Japan;(3) Department of Internal Medicine and Neurology, Mito Red Cross Hospital, Mito, Ibaragi, Japan;(4) Departnent of Internal Medicine and Pathology, Keio University, School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan
Abstract:Primary malignant lymphoma of the cauda equina is an extremely rare disease. Previously, there have been only 12 reported cases of malignant lymphoma of the cauda equina, and most cases relapsed early in the clinical course. So, the optimal treatment strategy for this condition has not been established yet and the prognosis is thought to be poor. We experienced a case of B-cell malignant lymphoma of the cauda equina, with rapid progression of the muscle weakness of the bilateral lower extremities, successfully treated with high-dose methotrexate plus high-dose cytarabine (Ara-C) chemotherapy, followed by radiotherapy and in complete remission without any recurrence signs, 1.5 years after the initial diagnosis. Intrathecal chemotherapy with MTX, Ara-C, and predonisolone was simultaneously performed. We should carefully continue to monitor the clinical course of our case, with the examinations of magnetic resonance imaging and cerebrospinal fluid in order not to overlook any subtle neurological changes or other clinical symptoms.
Keywords:
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号